Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CLDN3 |
| Upstream (Parents) |
|---|
| (<<) ELF3 → CLDN3 |
| (<<) SMAGP → CLDN3 |
| (<<) CLDN4 → CLDN3 |
| (<<) GPR35 → CLDN3 |
| (<<) ABHD11 → CLDN3 |
| Downstream (Children) |
|---|
| CLDN3 → TOX3 (>>) |
| CLDN3 → PIGZ (>>) |
| CLDN3 → ELF3 (>>) |
| CLDN3 → ZMYND8 (>>) |
| CLDN3 → OR10H2 (>>) |
| CLDN3 → TRIM15 (>>) |
| CLDN3 → VEGFA (>>) |
| CLDN3 → PLS1 (>>) |
| CLDN3 → HLTF (>>) |
| CLDN3 → NEU1 (>>) |
| CLDN3 → GRB7 (>>) |
| CLDN3 → ABHD11 (>>) |
